Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Fluoride
Hygiene Tools
Infection Control
Nutrition
Oral-Systemic Link
Scope of Practice
Oral Cancer: Page 41
'Homing beacon' immune cells may treat perio disease
By
DrBicuspid.com staff writers
Periodontal disease could be effectively treated by beckoning the right kind of immune system cells to the inflamed tissues, according to a new animal study by U.S. and Brazilian researchers published October 28 in
Proceedings of the National Academy of Sciences
.
October 31, 2013
Sinclair to sell VELscope in Canada
By
DrBicuspid.com staff writers
LED Medical Diagnostics has signed a distribution agreement with Sinclair Dental to sell LED's VELscope Vx oral cancer screening device in Canada.
October 29, 2013
Genetic markers may predict head/neck cancer risk
By
Donna Domino
Unique DNA markings may predict the risk of developing head and neck cancer, according to a study in the journal
Cancer
. The discovery may lead to the development of noninvasive tests for early precancer screening, allowing at-risk patients to get earlier treatment and improve their survival.
October 27, 2013
Oral bacteria create ethnic 'fingerprint'
By
DrBicuspid.com staff writers
The bacteria in the human mouth -- especially those under the gums -- are as powerful as a fingerprint at identifying a person's ethnicity, according to a new study in
PLOS One
.
October 23, 2013
U.K. survey supports HPV vaccine 'jab' for boys
By
DrBicuspid.com staff writers
An overwhelming majority of people in the U.K. support the human papillomavirus (HPV) vaccination for boys, according to a survey conducted on behalf of the British Dental Health Foundation.
October 22, 2013
DrBicuspid.com Oral Cancer & Diagnostics Insider
By
Donna Domino
October 22, 2013
Low-level laser therapy may reduce canker sores in HNSCC
By
DrBicuspid.com staff writers
Low-level laser therapy has shown promising results in reducing the occurrence of canker sores in head and neck squamous cell carcinoma (HNSCC) patients undergoing concurrent chemoradiotherapy.
October 20, 2013
MRI better predicts oral cancer survival
By
Rob Goszkowski
Magnetic resonance imaging (MRI) may be a better tool for predicting the chances of survival and tumor metastasis of patients with oral cancer, according to a new study by British researchers. They found that measuring tumor volume on MRI scans could offer a more accurate prognosis than analyzing the surface area of a tumor.
October 15, 2013
Pancreatic cancer biomarkers found in saliva
By
DrBicuspid.com staff writers
Cellular signals found between pancreatic cancer tumors and saliva support the validity of salivary diagnostics, according to a new study in
Journal of Biological Chemistry
.
October 9, 2013
Study: Free HNC screenings have positive impact
By
DrBicuspid.com staff writers
Offering free head and neck cancer (HNC) screenings annually to communities offers the possibility of early detection and the opportunity to increase the understanding of cancer risk factors, according to a new study.
October 8, 2013
LSU gets $3M to study HIV-related changes to oral bacteria
By
DrBicuspid.com staff writers
Louisiana State University (LSU) researchers have been awarded a $2.76Â million grant that will enable them to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth, and what effects those changes may have on oral infections in HIV disease.
October 7, 2013
Anticoagulation therapy reduces clot risk for HNC patients
By
Donna Domino
Head and neck cancer (HNC) patients who are hospitalized after surgery and do not receive anticoagulation therapy have an increased risk of blood clots, according to a study in
JAMA Otolaryngology--Head & Neck Surgery.
October 7, 2013
Previous Page
Page 41 of 116
Next Page